Study makes exciting progress in elucidating the mechanisms of bortezomib in lymphoma
Monday, July 12, 2010 - 12:28
in Health & Medicine
HACKENSACK, N.J. (July 12, 2010) — A new study by researchers from the John Theurer Cancer Center at Hackensack University Medical Center sheds light on how bortezomib (VELCADE®), the first...